Staff Reports
The Centers for Disease Control and Prevention (CDC) is getting set to make a decision about whether or not to permanently remove Pfizer and Moderna from liability for injuries caused by the COVID-19 vaccine.
The decision on whether or not to include the COVID-19 mRNA dosages in vaccination regimens for children and adolescents will be made by the appropriate authorities on Wednesday and Thursday of this week.
In the event that this takes place, the door will be opened for biotech companies to be protected from any lawsuits that arise from harm caused by immunizations. Any responsibility would be transferred to the National Vaccine Injury Compensation Program run by the United States Department of Health and Human Services. Pfizer and Moderna would then be allowed to market a dose that has been given permission to do so by the FDA if the approval were granted.
This vote takes place at a time when the liability shield afforded to these companies by the PREP Act, which went into effect in March 2020 and is likely to run out in the beginning of 2023.
The preceding is a summary of an article that originally appeared on Oann.
